Remove 2017 Remove FDA Remove Governance Remove Nursing Homes
article thumbnail

Health Provider News

Hall Render

Vincent reopens Westside Crossing Walk-In Care Indiana’s 2017 abortion law violates free speech, federal judge rules Ind. Parkview Hospitals Awarded ‘A’ In Hospital Safety Grades From Leapfrog Group New nurse apprenticeship program starts at Ascension St. million expansion ‘Very, very unusual.’

article thumbnail

Hall Render’s Health Provider News – January 28, 2022

Hall Render

FDA halts use of antibody drugs that don’t work vs. omicron. Healthcare groups urge Congress to extend Acute Hospital Care at Home waiver. Hospital discharge pressures build as nursing homes clamor for help. The nursing home staffing crisis right now is like nothing we’ve seen before. Medicare scheme.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Here are the major issues facing healthcare in 2021, according to PwC

Healthcare IT News - Telehealth

The virtual trial, to be sure, is not a new concept: One team of researchers counted more than 1,100 trials listed on ClinicalTrials.gov employing connected digital products for remote data collection in both 2017 and 2018, the organization observed. ” The FDA is hinting that some of these changes could be here to stay.

COVID-19 207
article thumbnail

A Health-Heavy State of the Union

Kaiser Health News

Biden’s calls for bipartisanship to extend health programs like pandemic-era subsidies for Affordable Care Act health plans are expected to clash with conservative demands to slash federal government spending. Rovner: Sarah, is the FDA worried about this case? I’m wondering when somebody is going to bring that up.

article thumbnail

Health Provider News

Hall Render

into cutting opioids in hospitals ISU and University of Utah partnership aims to combat Idaho’s mental health crisis Presbyterian-UnityPoint merger moves forward St.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) (federal government may unilaterally obtain dismissal of FCA claims, and calling the constitutionality of the FCA’s private enforcement mechanism into question) ( here ); Quishenberry v. Further, the plaintiffs’ arguments were based on scientific standards “not utilized by the FDA,” and thus preempted. Polansky v. 3d 239 (Cal.

FDA 105